Skip to content

Neoadjuvant electrochemotherapy for colorectal cancer - a randomized controlled trial

Status
Suspended
Phases
Phase 2
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2025-520755-91-00
Enrollment
12
Registered
2025-01-29
Start date
2025-01-31
Completion date
Unknown
Last updated
2025-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal cancer

Brief summary

Evaluation of serious adverse events (from study treatment to surgery), Evaluation of any adverse events reported (within 30 days after study treatment)

Detailed description

Changes in the tumor microenvironment, in terms of infiltrating lymphocytes, bulk and spatial gene and protein expression analysis, and spatial distribution and organization of bacteria in situ

Interventions

Sponsors

Region Sjaelland
Lead SponsorOTHER

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Design outcomes

Primary

MeasureTime frame
Evaluation of serious adverse events (from study treatment to surgery), Evaluation of any adverse events reported (within 30 days after study treatment)

Secondary

MeasureTime frame
Changes in the tumor microenvironment, in terms of infiltrating lymphocytes, bulk and spatial gene and protein expression analysis, and spatial distribution and organization of bacteria in situ

Countries

Denmark

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026